SHOE
Shoe Station Group Inc.
SHOE's fundamentals are weak and it looks expensive: trading at 16x earnings, above its usual 9.3x. Analysts expect earnings growth.
SHOE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
SHOE's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SHOE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.3x | $5.57 | -61% |
| Fair | 9.2x | $8.12 | -43% |
| Forward | 10x | $14.20 | — |
| Expensive | 15x | $13.27 | -6.5% |
| Current | 16x | $14.20 | — |
Historical ranges are pointers, not guarantees.
SHOE's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
SHOE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect SHOE's earnings to grow and its profitability to improve, with its revenue holding steady.
SHOE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.39 | +58% |
| Q3 2026 | $0.88 | -61% |
| Q2 2026 | $1.35 | -44% |
| Q1 2026 | $1.90 | -29% |
| Q4 2025 | $2.10 | -23% |
| Q3 2025 | $2.27 | -20% |
| Q2 2025 | $2.39 | -12% |
| Q1 2025 | $2.68 | 0% |
| Q4 2024 | $2.72 | -6.2% |
SHOE's earnings per share have fallen from their peak: $0.88 over the past year, against $5.42 in early 2022.
SHOE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $284.3M | -7.2% |
| Q2 2026 | $270.7M | -2.5% |
| Q1 2026 | $254.1M | -3.4% |
| Q4 2025 | $297.2M | -3.2% |
| Q3 2025 | $306.4M | -7.9% |
| Q2 2025 | $277.7M | -7.5% |
| Q1 2025 | $262.9M | -6.1% |
| Q4 2024 | $306.9M | -4.1% |
SHOE's revenue has slid since its 2021 peak: $284M last quarter, down 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | -5.6 points |
| Q2 2026 | -2.2% | -6.5 points |
| Q1 2026 | 4.3% | -1 points |
| Q4 2025 | 6.3% | -1.7 points |
| Q3 2025 | 8.2% | -0.8 points |
| Q2 2025 | 4.3% | -3.2 points |
| Q1 2025 | 5.3% | -1.8 points |
| Q4 2024 | 8% | -0.7 points |
SHOE's operating margin was 2.7% last quarter, down 5.6 points from the same quarter a year ago.
SHOE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +197% |
| Q2 2026 | $12.6M | +$35.6M |
| Q1 2026 | $27.7M | -24% |
| Q4 2025 | $19.7M | +138% |
| Q3 2025 | $2.2M | -88% |
| Q2 2025 | -$23M | -435% |
| Q1 2025 | $36.2M | -11% |
| Q4 2024 | $8.3M | -76% |
SHOE still generates free cash flow, though less than at its 2021 peak: $67M over the past year.
SHOE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -72K shares |
| 1 year | -0.5% | -140K shares |
| 3 years | -0.3% | -95K shares |
| 5 years | -4.7% | -1.3M shares |
| Available history | -6.2% | -1.8M shares |
SHOE has 27M diluted shares, down 0.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $7M |
| Q1 2025 | — |
| Q1 2024 | — |
| Q4 2023 | $5.4M |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
SHOE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
SHOE has more cash than debt.
SHOE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 71.0 | Neutral |
SHOE's weekly RSI is 45 (neutral) and its Stochastic is 71 (neutral).
SHOE PE vs Consumer Cyclical Sector
| Metric | SHOE | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 10% below |
| PE % | 85 | 47 | 38 pts above |
SHOE is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.
SHOE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.7 | 3.6% above |
| 20 week MA | $14.2 | 0.1% below |
| 50 week MA | $16.6 | 14% below |
| 100 week MA | $19.2 | 26% below |
| 200 week MA | $24.7 | 42% below |
SHOE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 42% below its 200-week average.
SHOE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.4 | +5.3% |
| 2021 | $19.4 | $39.3 | +102% |
| 2022 | $39.3 | $24.5 | -38% |
| 2023 | $24.5 | $30.2 | +23% |
| 2024 | $30.2 | $35.7 | +18% |
| 2025 | $35.7 | $18.1 | -49% |
| 2026 YTD | $18.1 | $14.2 | -21% |
SHOE's yearly returns have swung widely, from +102% in 2021 to −49% in 2025. It's down 21% so far in 2026.